Applications of Immunomodulatory Immune Synergies to Adjuvant Discovery and Vaccine Development
- PMID: 30470547
- DOI: 10.1016/j.tibtech.2018.10.004
Applications of Immunomodulatory Immune Synergies to Adjuvant Discovery and Vaccine Development
Abstract
Pathogens comprise a diverse set of immunostimulatory molecules that activate the innate immune system during infection. The immune system recognizes distinct combinations of pathogenic molecules leading to multiple immune activation events that cooperate to produce enhanced immune responses, known as 'immune synergies'. Effective immune synergies are essential for the clearance of pathogens, thus inspiring novel adjuvant design to improve vaccines. We highlight current vaccine adjuvants and the importance of immune synergies to adjuvant and vaccine design. The focus is on new technologies used to study and apply immune synergies to adjuvant and vaccine development. Finally, we discuss how recent findings can be applied to the future design and characterization of synergistic adjuvants and vaccines.
Keywords: adjuvant; antigen; immune synergy; immunology; vaccine.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
The path forward.Vaccine. 2015 Jun 8;33 Suppl 2:B60-3. doi: 10.1016/j.vaccine.2015.01.087. Vaccine. 2015. PMID: 26022572 Review.
-
New generation adjuvants--from empiricism to rational design.Vaccine. 2015 Jun 8;33 Suppl 2:B14-20. doi: 10.1016/j.vaccine.2015.01.088. Vaccine. 2015. PMID: 26022561 Review.
-
Modern Vaccines/Adjuvants Formulation--Session 2 (Plenary II): May 15-17, 2013--Lausanne, Switzerland.Hum Vaccin Immunother. 2013 Sep;9(9):2015-6. doi: 10.4161/hv.26208. Epub 2013 Aug 20. Hum Vaccin Immunother. 2013. PMID: 23966098 Free PMC article.
-
Gaps in knowledge and prospects for research of adjuvanted vaccines.Vaccine. 2015 Jun 8;33 Suppl 2:B40-3. doi: 10.1016/j.vaccine.2015.03.057. Vaccine. 2015. PMID: 26022566
-
Modern Vaccine Adjuvant/Formulation--Session 9: Adjuvants.Hum Vaccin Immunother. 2013 Sep;9(9):2013-4. doi: 10.4161/hv.26074. Epub 2013 Aug 12. Hum Vaccin Immunother. 2013. PMID: 23938771 Free PMC article.
Cited by
-
Targeting immunosenescence for improved tumor immunotherapy.MedComm (2020). 2024 Oct 28;5(11):e777. doi: 10.1002/mco2.777. eCollection 2024 Nov. MedComm (2020). 2024. PMID: 39473905 Free PMC article. Review.
-
Alum and a TLR7 agonist combined with built-in TLR4 and 5 agonists synergistically enhance immune responses against HPV RG1 epitope.Sci Rep. 2023 Oct 5;13(1):16801. doi: 10.1038/s41598-023-43965-3. Sci Rep. 2023. PMID: 37798448 Free PMC article.
-
Design, synthesis and biological evaluation of immunostimulating mannosylated desmuramyl peptides.Beilstein J Org Chem. 2019 Jul 29;15:1805-1814. doi: 10.3762/bjoc.15.174. eCollection 2019. Beilstein J Org Chem. 2019. PMID: 31467600 Free PMC article.
-
Plasmodium falciparum Malaria Vaccines and Vaccine Adjuvants.Vaccines (Basel). 2021 Sep 24;9(10):1072. doi: 10.3390/vaccines9101072. Vaccines (Basel). 2021. PMID: 34696180 Free PMC article. Review.
-
Bioinspired vaccines to enhance MHC class-I antigen cross-presentation.Curr Opin Immunol. 2022 Aug;77:102215. doi: 10.1016/j.coi.2022.102215. Epub 2022 Jun 4. Curr Opin Immunol. 2022. PMID: 35667222 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
